ACA
UTHR icon

Aptus Capital Advisors’s United Therapeutics UTHR Stock Holding History

Aptus Capital Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$246K Sell
415
-47
-10% -$23.4K ﹤0.01% 940
2025
Q4 		$225K Buy
+462
New +$215K ﹤0.01% 997
2023
Q1 		– Sell
-2,415
Closed -$672K – 899
2022
Q4 		$672K Sell
2,415
-671
-22% -$169K 0.02% 315
2022
Q3 		$646K Buy
+3,086
New +$690K 0.02% 297
2019
Q4 		– Sell
-16,879
Closed -$1.35M – 572
2019
Q3 		$1.35M Buy
16,879
+2,059
+14% +$166K 0.15% 157
2019
Q2 		$1.16M Buy
14,820
+363
+3% +$33.9K 0.16% 120
2019
Q1 		$1.7M Buy
14,457
+1,282
+10% +$149K 0.29% 82
2018
Q4 		$1.43M Buy
+13,175
New +$1.53M 0.38% 43

Other funds holding UTHR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return